Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07071077

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hypertension Behavior Cardiovascular Diseases Health Behavior Medication Adherence Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Delaware

Newark, Delaware, 19713, United States

Location status: Recruiting

Location contact

Yendelela Cuffee

CONTACT

[email protected]

302-831-1302

Yendelela Cuffee

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • African American/Black
  • Diagnosed with Hypertension
  • Prescribed medication for hypertension

Exclusion criteria

  • Cognitive limitations that limit the ability to provide informed consent
  • Pregnancy
  • Unable to speak or read English
  • Planning to relocate during the study period

Treatment and study plan

Web-Based Storytelling Intervention

Behavioral

The Web-based storytelling group will access stories and educational materials on the study website.

Group-Based Storytelling Plus Intervention

Behavioral

The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.

Primary outcomes

  1. Systolic and Diastolic Blood Pressure

    Time frame: 6 months

    Blood pressure will be measured three times using a manual blood pressure monitor.

  2. Adherence to Antihypertensive Medications (daily usage)

    Time frame: 6 months

    Medication adherence will be measured using Medication Electronic Measuring System (MEMS) caps

  3. Adherence to Antihypertensive Medications (self reported)

    Time frame: 6 months

    Medication adherence will be measure through participant self report Domains of Subjective Extent of Nonadherence scale.

Sponsors and collaborators

Lead sponsor

University of Delaware

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Official study title

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans With Hypertension

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 17, 2025
Registry last updated
Jul 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.